Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap13.28B
Enterprise Value13.24B
P/E Ratio-85.93
PEG Ratio-7.8
Price/Sales Ratio51.65
Price/Book Ratio4.24
Enterprise/Revenue48.68
Enterprise/EBITDA-114.66

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.53
Operating Margin-0.53
AD

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.09

Income Statement

Revenue220.23M
Revenue/Share0.39
Gross Profit170.15M
EBITDA-55.69M
Net Income-77.76M
Diluted EPS-0.16

Balance Sheet

Total Cash1.06B
Total Cash/Share2.21
Total Debt385,717
Total Debt/Equity0
Current Ratio17.73
Book Value Per Share4.17

Price History

52-Week Change-51.69
52-Week High40.37
52-Week Low16.3
Moving Average 50 Days19.31
Moving Average 200 Days23.85

Statistics

Average Volume16.66M
Shares Outstanding541.34M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split Factor1399:1000
Last Split DateMay 05, 2016
AD